Custom Search

Register
Sign In
Sign In Using Facebook

Botox Makers Agree To Pay $600 Million Penalty For Off-Label Use

by Gopalan T on  September 02, 2010 at 12:11 AM Corporate News
  •   Print
  •   Share
  •   Comments
  •  Text 
Allergan, the makers of the popular anti-wrinkle treatment Botox, have agreed to pay the US government 600 million dollars in penalty for so-called off-label uses.
 Botox Makers Agree To Pay $600 Million Penalty For Off-Label Use


The company said in a statement it agreed to plead guilty to a single misdemeanor "misbranding" charge covering the period 2000 through 2005 and pay up 375 million dollars.

It will pay an additional 225 million dollars to resolve civil claims from the Justice Department under the False Claims Act, which relates to fraud.

The misbranding case stems from the promotion of Botox for uses for which it had not been approved between 2000 and 2005, the company said.

During that time, its marketing resulted in uses for headache, pain, spasticity and juvenile cerebral palsy. Some of those uses were subsequently approved or are being considered.

"This settlement is in the best interest of our stockholders as it resolves all matters at issue in the investigation, avoids substantial costs of litigation, as well as the substantial risks to Allergan associated with government enforcement action in these matters, and permits us to focus our time and resources on productively developing new treatments for patients and the medical community," said Douglas Ingram, Allergan executive vice president.

The drugmaker is also required as part of the agreement to drop the lawsuit it filed against the FDA in October challenging a government rule that prohibits marketing drugs for unapproved uses. Allergan said it still anticipates the agency will decide on its migraine application this year.

Page 1 Page 1 | 2  Next
 Email Email   RSS Feeds RSS Feeds   Print this page Print   Save this page Save   Link Link   Syndicate Syndicate   Comments Comments   Bookmark and Share
 
Comment & Contribute
Be the first to comment!
Comments should be on the topic and should not be abusive. Comments are normally moderated and are reviewed after they are posted.
* Your comment can be maximum of 2500 characters

Notify me when reply is posted
I agree to the terms and conditions
  

X
  • Health News Index
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Dermatology
News Archive
Date :
Category :
Keyword :
Quiz on Botox
Botox is a safe, quick and simple treatment for wrinkles and frown lines and is becoming increasingly popular amongst women.
  • News Quick Links
News Central Health Watch
Latest Health News Health In Focus
News Category (500+) Breaking Health News
Popular News Celebrating Life
Health News and Press Release Medindia - Exclusive
News Photo Gallery India Special
News Video Gallery Lifestyle and Wellness
News From Other Resources
Botox
Complete Medindia Resources
News Categories:  
Child Health Center

Corporate Related News

» Pfizer Initiates Recall of Birth Control Pills in the US » J&J Initiates Voluntary Recall of Aveeno Baby Lotion
» Fortis to Launch Chain of Dialysis Centers to Broaden Access to Quality Care » Pacific Edge Buoyed by European Acceptance of Gastric Cancer Detection Patents
» FDA Approves Abbott’s Xience Prime Coronary Stent » Circadian Technologies’ Investigative Cancer Drug Receives FDA Nod for Clinical Trials
» CooperVision Issues Another Statement Over Contact Lens Recall » Conditional Nod for Proposed Teva Buy
Read More >>